What each platform's own policy says
We read the acceptable use policy of each platform below on November 1, 2026 and link straight to it. Nothing here comes from forum rumors or review sites. Where a policy shows a last-updated date, it's next to the link.
| Platform | What its policy says | Policy |
|---|---|---|
| BrevoNamed | Bans peptide-based products for injectable or oral therapeutic, weight-loss or performance use, including products labeled "research use only", whether or not they're legal where the recipient lives. The clause was added in mid-2026. | Read policy |
| OmnisendNamed | Bans unauthorized or illegally distributed pharmaceutical products and prescription medications, and says that includes "drugs for research purposes". | Read policyUpdated April 30, 2026 |
| KlaviyoCovered | You may not use it to offer prescription medications or "pharmaceutical products or services". Peptides aren't named, but sellers have reported accounts disabled under this rule. | Read policyUpdated April 9, 2026 |
| MailchimpCovered | Lists "pharmaceutical products" among the businesses it may not allow, and puts supplements under additional scrutiny. | Read policyUpdated September 26, 2025 |
| Shopify EmailCovered | Shopify's own policy lists no products. But Shopify Email sends through SendGrid, and Shopify's terms make you subject to Twilio's acceptable use policy, whose email rules ban unapproved health claims and advertising prescription drugs. | Read policyUpdated April 9, 2026Shopify terms, 9.7 |
| ActiveCampaignCovered | Bans messages about drugs, prescription or over the counter, and any product that claims to diagnose, cure, treat or prevent a disease. The broadest health wording on this list. | Read policyUpdated October 19, 2026 |
| HubSpotCovered | Names "pharmaceutical products" as a restricted industry it can cut off at its discretion. | Read policyUpdated September 16, 2026 |
| GetResponseCovered | Bars marketing for drugs of any kind, prescription or over the counter, and for medicines. | Read policyUpdated September 24, 2026 |
| DripCovered | Bans emails that offer drugs or pharmaceutical information or products. | Read policyUpdated November 15, 2024 |
| SendlaneCovered | Businesses offering pharmaceutical products can't use the service. | Read policyUpdated February 22, 2024 |
| Constant ContactCovered | Can suspend accounts for online and direct pharmaceutical sales, including prescription drugs. | Read policyUpdated September 1, 2026 |
| MoosendCovered | Nearly the same wording as Constant Contact: can suspend accounts for online and direct pharmaceutical sales. | Read policyUpdated June 2025 |
| Kit (ConvertKit)Not named | Bans online pharmacies, prescription medicine sales and misleading health promises. Most new accounts are reviewed by hand before they can send. | Read policyUpdated May 7, 2026 |
| MailerLiteNot named | No drug or pharmaceutical category, but bans weight-loss material and content that could pose a health risk. | Read policyUpdated September 22, 2026 |
| AWeberNot named | No published industry list beyond lawful use. | Read policy |
Why peptide stores get approved, then shut off
Getting approved at signup usually isn't a policy review. That tends to come later: a send gets flagged, someone complains, or a reviewer looks at your store. Mailchimp, HubSpot, Constant Contact and Moosend all reserve the right to suspend restricted industries at their discretion, so a quiet approval isn't a yes.
The other reason is how these platforms send. Most of them mail for many customers from shared servers, so a category they see as risky is a risk to everyone else on those servers. Turning you away is the cheapest fix they have.
Before you move your list anywhere
- Ask in writing. Email the platform's support, say exactly what you sell, and keep the reply. A written yes is worth more than an account that hasn't been reviewed yet.
- Read the policies it points to. Shopify Email is the example: the rule that matters lives in its sending provider's terms, not Shopify's.
- Send from your own domain. Use a sending subdomain like send.yourbrand.com with SPF, DKIM and DMARC set up, so your sending reputation belongs to your domain and moves with you.
- Warm it up. Start with your most recent buyers and openers and raise volume over a few weeks. A cold list blasted from a new domain lands in spam.
- Keep the copy inside the lines. Research-use language, no dosing, no health claims, and a postal address and unsubscribe link in every email.
- Export on a schedule. A frozen account may not let you export, and signups who never bought often exist only in the email platform.
If your account just got shut off
- Ask for a data export right away, in writing, before the account is closed.
- Pull your customers from your store. WooCommerce and Shopify both hold your buyers and their marketing consent.
- Don't upload everything and hit send. Start the new platform with your most engaged people and warm the domain up first.
- Replace your signup forms. Forms tied to the old account stop collecting, so new signups go nowhere until they're swapped.
- Keep consent records, meaning when and where each person signed up, so you can show permission if you're asked.
Where TellySend fits
TellySend is email marketing built for peptide, supplement and research-use brands. The category is who it's for, not something that gets flagged in a review. Each brand sends from its own sending domain, warmed up gradually, with flows, campaigns, segments, signup forms and revenue tracking, and a WooCommerce plugin that connects the store. It's run for you end to end.